PSA Levels and the Probability of Prostate Cancer on Biopsy

By Gretzer M.B.   Partin A.W.  

European Urology Supplements, Vol. 1, Iss. 6, 2002-09 ,pp. : 21-27

Elsevier

Access to resources Recommend Favorite

Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled study

By Mkinen T.   Auvinen A.   Hakama M.   Stenman U.-H.a.   Tammela T.L.J.  

Urology, Vol. 60, Iss. 5, 2002-11 ,pp. : 846-850

Elsevier

Access to resources Recommend Favorite

IGF, PSA, glandular hyperplasia and cancer risk in the prostate

By Barrass B.J.R.   Persad R.A.   Gillatt D.A.   Neal D.E.   Hamdy F.C.   Oliver S.E.   Gunnell D.J.   Donovan J.L.   Peters T.J.   Holly J.M.P.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 83-83

Elsevier

Access to resources Recommend Favorite

Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSA - what's new in 1997

By Kalish L.A.   McKinlay J.B.  

Urology, Vol. 54, Iss. 6, 1999-12 ,pp. : 1022-1027

Elsevier

Access to resources Recommend Favorite

Correlation of Initial PSA Level and Biopsy Features with PSA-Doubling Time in Early Stage Prostate Cancers in Japanese Men

By Kakehi Y.   Kamoto T.   Shiraishi T.   Kato T.   Tobisu K.-i.   Akakura K.   Egawa S.   Maeda O.   Sumiyoshi Y.   Arai Y.   Ogawa O.  

European Urology, Vol. 41, Iss. 1, 2002-01 ,pp. : 47-53

Elsevier

Access to resources Recommend Favorite